Oral pan-erbB tyrosine kinase inhibitor shows evidence of activity, good tolerance in phase I Nov. 8, 2001
First report of potent and selective inhibitors of c-Src protein tyrosine kinase identified at Ariad Nov. 7, 2001
AP-5280, a polymer-linked platinum antitumor agent, shows promising preclinical activity Nov. 7, 2001
RSS